Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities Not Included in Calculation of Diluted Net Loss per Share (Details) - shares	9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	32,416,078	32,758,364
Options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	6,735,314	2,572,850
Placement agent warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	28,333	28,333
Time based Stock Appreciation Rights
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	418,722	499,977
Stock Appreciation Rights from exercised Series B Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	100,059	0
Potential additional Stock Appreciation Rights from Series B Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	280,783	999,953
Potential Stock Appreciation Rights from Series A Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	0	999,953
Series A Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	0	8,666,667
Series B Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	2,557,967	8,666,667
Tranche 2 Share rights
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	0	4,662,005
Tranche 3 Share rights
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	0	4,662,005
Potential Tranche 2 SARs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	0	499,977
Potential Tranche 3 SARs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	0	499,977
February 2026 common warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock ( in shares)	22,294,900	0